167 related articles for article (PubMed ID: 34195183)
1. Construction of Two Alternative Polyadenylation Signatures to Predict the Prognosis of Sarcoma Patients.
Hu C; Liu C; Li J; Yu T; Dong J; Chen B; Du Y; Tang X; Xi Y
Front Cell Dev Biol; 2021; 9():595331. PubMed ID: 34195183
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
3. Identification of Iron Metabolism-Related Gene Signatures for Predicting the Prognosis of Patients With Sarcomas.
Li J; Hu C; Du Y; Tang X; Shao C; Xu T; Zhao Z; Hu H; Sheng Y; Guo J; Xi Y
Front Oncol; 2020; 10():599816. PubMed ID: 33489900
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
Hu C; Chen B; Huang Z; Liu C; Ye L; Wang C; Tong Y; Yang J; Zhao C
J Transl Med; 2020 Sep; 18(1):337. PubMed ID: 32873319
[TBL] [Abstract][Full Text] [Related]
5. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
[TBL] [Abstract][Full Text] [Related]
6. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
7. Systemic Analysis of the Prognosis-Associated Alternative Polyadenylation Events in Breast Cancer.
Zhang Y; Wang Y; Li C; Jiang T
Front Genet; 2020; 11():590770. PubMed ID: 33329736
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Prognostic Risk Signatures of Soft Tissue Sarcoma Based on Ferroptosis-Related Genes.
Huang W; Duan Y; Yang X; Shang C; Chen X; Zhang H; Li F
Front Oncol; 2021; 11():629868. PubMed ID: 33889544
[TBL] [Abstract][Full Text] [Related]
9. Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients.
Wang Y; Li J; Shao C; Tang X; Du Y; Xu T; Zhao Z; Hu H; Sheng Y; Hu C; Xi Y
BMC Cancer; 2021 Jan; 21(1):58. PubMed ID: 33435917
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
12. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
13. Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells.
Hu C; Wang Y; Liu C; Shen R; Chen B; Sun K; Rao H; Ye L; Ye J; Tian S
Med Sci Monit; 2020 Jul; 26():e924126. PubMed ID: 32683393
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
15. An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma.
Yang H; Han X; Hao Z
Front Mol Biosci; 2021; 8():679474. PubMed ID: 34291084
[No Abstract] [Full Text] [Related]
16. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma.
Chen L; Zeng H; Du Z; Zhao Y; Ma X
Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
19. Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer.
Cheng Y; Li X; Dai Y; Dong Y; Yang X; Wang J
J Gynecol Oncol; 2021 May; 32(3):e30. PubMed ID: 33559412
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients.
Mao AW; Barck H; Young J; Paley A; Mao J-; Chang H
Clin Transl Oncol; 2022 Mar; 24(3):597-604. PubMed ID: 34741726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]